November 16, 2007 — /PRNewswire/ — GERMANTOWN, WI — Cambridge Major Laboratories today announced the acquisition of ChemShop B.V., Weert, the Netherlands, a European supplier of active pharmaceutical ingredient (API) development services. The newly combined company is one of the largest pharmaceutical chemistry development organizations in the western hemisphere, with over 140 employees at 3 sites in the U.S. and Europe. Carrying forward ChemShop will adopt the name Cambridge Major Laboratories Europe.
ChemShop has built an impeccable reputation in the pharmaceutical chemistry outsourcing sector, providing process development and GMP manufacturing services for the past nine years. All of ChemShop’s management and personnel will continue to operate the business at the Weert facility which includes R&D laboratories, GMP kilo lab suites, and a GMP pilot plant. The ChemShop facility provides intermediates and API’s from grams to hundreds of kilograms scale.
As part of its commitment to global operations and to support its tremendous growth, Cambridge Major will invest several million dollars to expand the European site which will include more reactor capacity, laboratories, and expansion of the company’s high potency API (“HPAPI”) manufacturing capabilities to keep the ChemShop site on a fast growth track. The planned expansion will commence immediately and be completed in the second half of 2008.
“The addition of ChemShop presents an enormous opportunity for both companies to further tap into the growing European pharmaceutical market and to penetrate deeper into the US market as we leverage our combined technical expertise and human resources,” says Michael W. Major, president and CEO, Cambridge Major Laboratories. “More importantly, both organizations share the same mentality and business approach which will guarantee seamless integration and will further bolster CML’s technological reputation and expand its global capabilities in API-related chemistry services.”
“We are excited to serve the industry together with Cambridge Major and we are convinced that the combined expertise will create a unique company able to provide even better performance than before,” says Peter Van Tilburg, CEO, ChemShop B.V. “The synergies between both companies are truly fantastic and will without any doubt result in a huge added value for our customers.”
About Cambridge Major Laboratories
Cambridge Major Laboratories, Inc. is a leading global service-based chemistry outsourcing partner to the pharmaceutical and biotechnology industries, producing pharmaceutical intermediates, active pharmaceutical ingredients, and other fine organic chemicals. The company specializes in chemical process development and advanced multi-step organic synthesis, and operates out of three facilities in the U.S. and Europe. The company has been FDA inspected and approved for cGMP manufacturing.
Source: Cambridge Major Laboratories